Zydus and Synthon Forge Exclusive License for Ozanimod Capsules Application in the U.S. Market Zydus Lifesciences has partnered with Synthon to exclusively license Ozanimod Capsules in the U.S. market, enhancing access to vital medications.

Zydus and Synthon Forge Exclusive License for Ozanimod Capsules Application in the U.S. Market #India #Ahmedabad #Zydus_Lifesciences #Synthon #Ozanimod_Capsules